New drug combo trial aims to control advanced stomach cancer
NCT ID NCT07406633
Summary
This study is testing whether adding an experimental drug called KQB198 to the standard treatment imatinib is safe and more effective for people with advanced gastrointestinal stromal tumors (GIST). It will involve about 46 patients who are starting their first treatment for cancer that has spread. Researchers will measure how well the combination shrinks tumors and controls the disease over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIST are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.